IRVING, Texas - McKesson Corporation (NYSE: NYSE:MCK), a $76 billion healthcare giant with "GREAT" financial health according ...

McKesson Corporation MCK recently announced that it has signed a definitive agreement to acquire a controlling interest in ...

Irving-based McKesson (NYSE: MCK) announced on Feb. 4 an agreement to buy an 80% controlling interest in New Providence, New ...

Based on our third quarter performance, we are raising and narrowing our guidance range for fiscal 2025 Adjusted Earnings per Diluted Share to $32.55 to $32.95. We are also pleased to announce the ...

McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions ...

Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors ...

McKesson Corporation (NYSE: MCK) announced today that it signed a definitive agreement to acquire a controlling interest in PRISM Vision Holdings, LLC (PRISM Vision), a premier provider of general ...

McKesson Co. (NYSE:MCK – Get Free Report)’s stock price was down 5.6% during trading on Thursday after the company announced weaker than expected quarterly earnings. The company traded as low as $575.

McKesson said it will acquire an 80% interest in the provider of general ophthalmology and retina management services. PRISM ...

This will allow us to expand our suite of solutions and continue to pursue our purpose of advancing health outcomes for all.” This transaction will enable McKesson to deliver on several key ...